PreTerm Birth Clinical Trial
Official title:
Efficacy and Safety of Deferred Umbilical Cord Clamping Compared to Umbilical CordMilking in Preterm Infants: A Randomized Clinical Trial
NCT number | NCT02996799 |
Other study ID # | 409-16 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | January 2017 |
Est. completion date | June 2023 |
For preterm infants, deferred cord clamping has been shown to improve both short term and long-term neonatal outcomes without an established harm for both the mother and her infant.The interference with resuscitative measures for the neonate or the mother is a risk that continued to hamper the implementation of delayed cord clamping in many centers around the world.For that reason, the evidence now is seeking a time-honored, yet not adopted method of placental transfusion that involves milking of the umbilical cord.
Status | Recruiting |
Enrollment | 180 |
Est. completion date | June 2023 |
Est. primary completion date | June 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Preterm infants < 32 weeks gestation confirmed by first trimester US Exclusion Criteria: - Any proven or suspected congenital or chromosomal abnormalities - Placenta previa or abruption - Cord prolapse - Known Rh sensitization - Fetal hydrops - Monochorionic multiples |
Country | Name | City | State |
---|---|---|---|
Saudi Arabia | King Abdulaziz University Hospital | Jeddah |
Lead Sponsor | Collaborator |
---|---|
King Abdulaziz University |
Saudi Arabia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Intraventricular haemorrhage | Any IVH diagnosed by cranial ultrasound | twenty eight days | |
Secondary | Need for resuscitation | Cardiac compression or medications at birth | one hour | |
Secondary | Apgar score at one minute | Calculated Apgar score at one minute | one minute after delivery | |
Secondary | Apgar score at 5 minutes | Calculated Apgar score at 5 minutes | 5 minutes after delivery | |
Secondary | The need for blood transfusion during hospital stay | The number of blood transfusions during hospital stay | one month | |
Secondary | Venous Hgb | Hgb at birth | 2 days | |
Secondary | Venous hematocrit | Hematocrit at birth | 2 days | |
Secondary | Bilirubin level | First bilirubin level after birth | 24 hours after birth | |
Secondary | Maximum bilirubin level | Highest bilirubin level | first week of life | |
Secondary | Polycythemia | If venous hematocrit more than 65% | first 48 hours after birth | |
Secondary | Respiratory distress syndrome | The need for surfactant administration | 48 hours after birth | |
Secondary | Oxygen dependency | first 28 days after birth and/or 36 weeks corrected age | first 28 days after birth and 36 weeks corrected age | |
Secondary | Need for volume administration | Need for bolus administration first 24 hours after birth | 24 hours after birth | |
Secondary | Use of inotropes | Use of any kind of inotropes in the first 24 hours | First 24 hours | |
Secondary | Necrotizing enterocolitis | Bell stage II or more | one month | |
Secondary | Mortality in hospital | Death before discharge | one month | |
Secondary | Sepsis | Positive blood culture | one month | |
Secondary | Maternal mortality | Maternal death after delivery in hospital | 2 weeks | |
Secondary | Post partum hemorrhage | Maternal estimated blood loss more than 500 mls in the first 24 hours after birth | one day | |
Secondary | Maternal need for blood transfusion | Maternal blood transfusion in the first 48 hours after delivery | First 48 hours after delivery | |
Secondary | Length of third stage | The time from delivery of the infant until delivery of placenta | 24 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Completed |
NCT05502510 -
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
|
||
Not yet recruiting |
NCT03418311 -
Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome
|
N/A | |
Not yet recruiting |
NCT03418012 -
Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB
|
N/A | |
Completed |
NCT02993744 -
Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone
|
N/A | |
Active, not recruiting |
NCT02673216 -
Infection and Adverse Pregnancy Outcome
|
||
Completed |
NCT01683565 -
Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood
|
Phase 4 | |
Completed |
NCT01460576 -
Improving Prematurity-Related Respiratory Outcomes at Vanderbilt
|
N/A | |
Completed |
NCT01412931 -
Protein and Ultrasound Indicators of Preterm Birth
|
N/A | |
Completed |
NCT02606058 -
The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures?
|
N/A | |
Terminated |
NCT03715530 -
Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women
|
N/A | |
Completed |
NCT00422526 -
Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial
|
Phase 3 | |
Enrolling by invitation |
NCT04251260 -
Effectiveness of Positioning in Preterm Neonates
|
N/A | |
Completed |
NCT03668860 -
India Dexamethasone and Betamethasone
|
Phase 1 | |
Recruiting |
NCT03638037 -
Correlation Between Maternal Vitamin D Level And Preterm Birth
|
||
Completed |
NCT02225353 -
Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery
|
Phase 2 | |
Recruiting |
NCT03992534 -
The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth
|
Phase 1 | |
Completed |
NCT03144141 -
Association Between EHG and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery
|
N/A | |
Completed |
NCT05210985 -
Examination of the Relationship Between Home Affordances With Development
|
||
Completed |
NCT04811742 -
Effect of Immersion Bathing and Showering Applications on Comfort Level and Physiological Parameters of Newborn
|
N/A |